Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR

被引:1
|
作者
He, Wenyin [1 ]
Yuan, Ying [1 ]
Liang, Junyu [1 ]
Fan, Xuejiao [1 ]
Li, Lei [1 ]
Pan, Xingfei [2 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Prov Clin Res Ctr Obstet & Gynecol, Guangdong Prov Key Lab Major Obstet Dis,Dept Clin, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Prov Clin Res Ctr Obstet & Gynecol, Guangdong Prov Key Lab Major Obstet Dis,Dept Infec, Guangzhou, Peoples R China
关键词
Mycoplasma genitalium; macrolide; fluroquinolone; 23S rRNA; parC; nested real-time PCR; INFECTION;
D O I
10.3389/fcimb.2023.1271392
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Traditional drug susceptibility testing cannot be performed in clinical laboratories due to the slow-growing characteristics of Mycoplasma genitalium when cultured in vitro. Sanger sequencing is the standard method for detecting drug resistance-associated mutations. It has been used in some laboratories to guide the choice of macrolide antibiotics for Mycoplasma genitalium infected patients. Furthermore, resistance to fluoroquinolone has become another emerging clinical challenge.Objective Sequencing analysis can detect unknown mutations, but it is time-consuming, requires professional analytical skills and the appropriate testing equipment. The main objective of this study was to establish a nested real-time PCR method for the simultaneous detection of 23S rRNA and parC genotypes in relation to the macrolide and fluoroquinolone resistance.Results 105 MG-positive samples and 27 samples containing other pathogens were used for validation. The limit of the nested real-time PCR detection was 500 copies/reaction and there was no cross-reaction with Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis, Neisseria gonorrhoeae, Human papillomavirus, Herpes simplex virus, Candida albicans and Ureaplasma parvum, but the 23S rRNA assay cross-reacted with Mycoplasma pneumoniae. Compared with sequencing results, the sensitivity of 23S rRNA was 100% (95% CI; 93.3 -100), the specificity was 94.3% (95% CI; 79.4 - 99.0), the overall consistency was 98% (95% CI; 92.5 - 99.7) and kappa value was 0.96 (P < 0.001); the sensitivity of parC was 100% (95% CI; 93.4 - 100), the specificity was 89.7% (95% CI; 71.5 - 97.3) and the overall consistency was 96.9% (95% CI; 90.7 - 99.2) with a kappa value of 0.92 (P < 0.001).Conclusions The results of this sensitive and rapid alternative for identifying resistant genotypes of Mycoplasma genitalium are intuitive and easy to interpret, especially for mixed MG populations. Although the relevant 23S rRNA primers need further adjustment, this reliable method would provide an effective diagnostic tool for the selection of antibiotics in clinical practice.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] SIMPLEPROBE PCR ASSAY FOR DETECTION OF MUTATIONS ASSOCIATED WITH MACROLIDE RESISTANCE IN MYCOPLASMA GENITALIUM SAMPLES
    Gosse, Marianne
    Lysvand, Hilde
    Pukstad, Brita
    Nordbo, Svein Arne
    SEXUALLY TRANSMITTED INFECTIONS, 2019, 95 : A269 - A269
  • [22] Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens
    Xiao, Li
    Waites, Ken B.
    Wang, Hong
    Van Der Pol, Barbara
    Ratliff, Amy E.
    Geisler, William M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (02) : 123 - 125
  • [23] Development of a Real-Time PCR Assay for Detection of Macrolide Resistance Mutations in Mycoplasma genitalium and Its Application for Epidemiological Surveillance in Russia
    Edelstein, Inna Alexandrovna
    Romanov, Andrey Vyacheslavovich
    Kozlov, Roman Sergeevich
    MICROBIAL DRUG RESISTANCE, 2023, 29 (03) : 69 - 77
  • [24] Phenotypic antibiotic resistance of Mycoplasma genitalium and its association to macrolide resistance-associated mutations
    Doelman, T.
    Adriaens, N.
    Bruisten, S.
    Westerhuis, B.
    Bouwman, F.
    Vergunst, C.
    van Dam, A.
    SEXUAL HEALTH, 2024, 21 (04) : 5 - 5
  • [25] Determination of Gene Mutations Associated with Macrolide and Fluoroquinolone Resistance in Patients Infected with Mycoplasma genitalium
    Caliskan, Zeynep Cansu
    Tanriverdi, Elif Seren
    Uzun, Mertcan
    Otlu, Baris
    Zarakolu, Pinar
    MIKROBIYOLOJI BULTENI, 2024, 58 (04): : 353 - 365
  • [26] Development of an endpoint genotyping assay to detect the Mycoplasma pneumoniae 23S rRNA gene and distinguish the existence of macrolide resistance-associated mutations at position 2063
    Suzuki, Yu
    Seto, Junji
    Shimotai, Yoshitaka
    Ikeda, Tatsuya
    Yahagi, Kazue
    Mizuta, Katsumi
    Matsuzaki, Yoko
    Hongo, Seiji
    JOURNAL OF MICROBIOLOGICAL METHODS, 2016, 131 : 130 - 134
  • [27] Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia
    Ertl, Nicole G.
    Anderson, Taylah K.
    Pardo, Carolyn J.
    Maidment, Toby, I
    Murray, Gerald L.
    Bradshaw, Catriona S.
    Whiley, David M.
    Sweeney, Emma L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (02) : 467 - 469
  • [28] Detection of 23S rRNA mutations associated to macrolide-resistance of Helicobacter pylori by PCR and a reverse hybridization line probe assay
    van Doorn, LJ
    Debets-Ossenkopp, YJ
    Marais, A
    van Hoek, K
    Sanna, R
    Mégraud, F
    Kusters, JG
    Quint, WGV
    GUT, 1998, 43 : A7 - A8
  • [29] Mycoplasma genitalium and Macrolide Resistance-associated Mutations in the Skane Region of Southern Sweden 2015
    Forslund, Ola
    Hjelm, Max
    El-Ali, Raghd
    Johnsson, Annika
    Bjartling, Carina
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (10) : 1235 - 1238
  • [30] Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens
    Le Roy, Chloe
    Henin, Nadege
    Bebear, Cecile
    Pereyre, Sabine
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (03) : 978 - 979